Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • edgeR, "DGELIst" function, "group" parameter

    Hi,

    I am using edgeR for some RNASeq analysis. My question concerns the DGEList function and its "group" parameter. I realized that, whether doing group=mydesignfactor or group=rep(1,ncol(counts)), the cpm numbers that I get after
    counts.TMM <- calcNormFactors(counts.DGEList)
    cpm.TMM=cpm(counts.TMM, normalized.lib.sizes=TRUE)
    are strictly identical in either case. The only difference between both ways is that the counts.TMM$samples$group column duly reflects what I put in in "group".

    Is this normal? What is it that I am missing? Is the "group" nevertheless taken into account on the subsequent estimateGLMCommonDisp, estimateGLMTrendDisp, estimateGLMTagDisp, glmFit, glmLRT etc.?

    Thanks in advance for your help.

    Best,

    David Rengel

  • #2
    There's no reason that cpm should be dependent upon your experimental design (in fact, it shouldn't be). The various GLM function pay attention to the design, since that's where it's important.

    Comment


    • #3
      Hi dpryan,

      THanks for your reply. Yes, that is right. My only only doubt came from de fact that if normalized.lib.sizes=TRUE, then the cpm are calculated using the normalization factors, which I thought were somehow dependent on your experimental design, but it seems I was mistaken.

      David

      Comment


      • #4
        Correct, normalization factors are independent from experimental design.

        Comment


        • #5
          Thanks a lot!

          Comment

          Latest Articles

          Collapse

          • seqadmin
            Current Approaches to Protein Sequencing
            by seqadmin


            Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
            04-04-2024, 04:25 PM
          • seqadmin
            Strategies for Sequencing Challenging Samples
            by seqadmin


            Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
            03-22-2024, 06:39 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by seqadmin, 04-04-2024, 09:00 AM
          0 responses
          34 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-04-2024, 08:48 AM
          0 responses
          28 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 04-01-2024, 06:45 AM
          0 responses
          45 views
          0 likes
          Last Post seqadmin  
          Started by seqadmin, 03-27-2024, 06:37 PM
          0 responses
          32 views
          0 likes
          Last Post seqadmin  
          Working...
          X